|
0
|
|
Covalent PPARgamma inverse agonism by FX-909 reveals mechanistic insights into therapeutic targeting of PPARgamma/RXRalpha-activated urothelial carcinoma.
(linkinghub.elsevier.com)
|
Stuckey JI
…
Sims RJ 3rd
Cell Chemical Biology
2026-06-18
|
#transcription
#cancer
#protein structure
#drug discovery
|
|
0
|
|
Light-driven thermotropic hydrogel with nanomodulator enables lipid intervention and cavity delivery for postsurgical tumor therapy.
(linkinghub.elsevier.com)
|
Zhong Z
…
Huang Y
Cell Reports Medicine
2026-06-18
|
#cancer
#immunotherapy
#ferroptosis
#macrophage
#drug delivery
|
|
0
|
|
Dangerous liaisons: Promiscuous inhibition of CHK1 and AMPK is a lethal affair for cancer cells.
(linkinghub.elsevier.com)
|
Lu EL
…
Scott JW
Cell Chemical Biology
2026-06-18
|
#cancer
#synergy
#kinase
|
|
0
|
|
Small-molecule inhibitors of the protein kinase DYRK as potential therapeutic candidates in cancer.
(linkinghub.elsevier.com)
|
Venkataramani P
…
Tonks NK
Cell Chemical Biology
2026-06-18
|
#cancer
#kinase
#drug discovery
#inhibitor
#glioblastoma
|
|
0
|
|
Structure-based design of Sec61 translocon targeting prodrugs minimize off-target toxicity.
(linkinghub.elsevier.com)
|
Hao Q
…
Yao G
Cell Chemical Biology
2026-06-18
|
#cancer
#cryo-em
#prodrug
#structure_based_design
#protein-drug interaction
|
|
0
|
|
CD4(+) T cells impair tumor growth through IL-3 and TNF-dependent vascular damage.
(science.org)
|
Lian Q
…
Bosselut R
Science
2026-06-18
|
#immunity
#transcriptomics
#cancer
#inflammation
|
|
0
|
|
GMHAN: A Heterogeneous Graph Attention Framework for Prioritizing Coding and Non-coding Driver Genes.
(academic.oup.com)
|
Meng P
…
Wang G
Bioinformatics
2026-06-18
|
#cancer
#machine learning
#oncogenesis
#network analysis
#driver genes
|
|
0
|
|
Management of Differentiated Thyroid Cancer.
(nejm.org)
|
Hegedus L
…
Tuttle RM
New England Journal of Medicine
2026-06-18
|
#cancer
#surveillance
#risk stratification
#molecular characterization
|